Filing Details

Accession Number:
0001179110-12-011595
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-07-17 16:18:53
Reporting Period:
2012-07-16
Filing Date:
2012-07-17
Accepted Time:
2012-07-17 16:18:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1311241 Intermolecular Inc IMI Semiconductors & Related Devices (3674) 201616267
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1528647 L. Peter Eidelman Intermolecular, Inc.
3011 North First Street
San Jose CA 95134
Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Acquisiton 2012-07-16 6,500 $0.20 18,875 No 4 M Direct
Common Stock, $0.001 Par Value Disposition 2012-07-16 6,500 $7.28 12,375 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2012-07-16 6,500 $0.00 6,500 $0.20
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
306,000 2016-05-04 No 4 M Direct
Footnotes
  1. The sale reported was effected pursuant to a Rule 10b5-1 Sales Plan adopted by the Reporting Person on May 14, 2012.
  2. The option was immediately exercisable in full on May 5, 2006; however, the shares vested pursuant to the following schedule: Twenty-Five Percent (25%) of the shares subject to the original option (312,500) vested on the first anniversary measured from February 27, 2006 (the "Vesting Commencement Date") and the remaining shares subject to the option vested in 36 successive, equal monthly installments thereafter on each monthly anniversary of the Vesting Commencement Date.
  3. The transaction was executed in multiple trades in prices ranging from $7.17 to $7.45, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.